Small-molecule combinationsexpand hematopoietic stem cell EX vivo and in vivo
Ended Project Grant Awarded Last action
- Award ID
- R41HL145877
- Recipient
-
Advac Therapeutic LLC UEI JXDHQYNC4JQ9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $609,705
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Philadelphia, PA 19146, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $203,302 | |
| Amendment | $203,302 | |
| Original award | $203,101 |
Show all 12
Quick answers
Who received award R41HL145877?
R41HL145877 was awarded to Advac Therapeutic LLC by National Heart Lung and Blood Institute (National Institutes of Health) on September 15, 2019.
How much is award R41HL145877 worth?
$609,705 has been obligated on R41HL145877.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award